Franz M.N.H. Schramel

Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer

Jan P. van Meerbeeck, G. Kramer, Paul Van Schil et al. · JNCI Journal of the National Cancer Institute · 2007 · 707 citations · Full text

Three-Arm Randomized Study of Two Cisplatin-Based Regimens and Paclitaxel Plus Gemcitabine in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group—EORTC 08975

Egbert F. Smit, J.P.A.M van Meerbeeck, P. Lianes et al. · Journal of Clinical Oncology · 2003 · 351 citations

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975

Fabio Efficace, Andrew Bottomley, Egbert F. Smit et al. · Annals of Oncology · 2006 · 182 citations

Quality Of Life, Life Assessment, Self-reported Health-related Quality +10

Gemcitabine and Cisplatin as Induction Regimen for Patients With Biopsy-Proven Stage IIIA N2 Non–Small-Cell Lung Cancer: A Phase II Study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955)

Nico van Zandwijk, Egbert F. Smit, G. Kramer et al. · Journal of Clinical Oncology · 2000 · 147 citations

Defining a standard set of patient-centred outcomes for lung cancer

Kimberley S. Mak, A.C.M. van Bommel, Caleb Stowell et al. · European Respiratory Journal · 2016 · 112 citations · Full text

Palliative Care, Advanced Lung Disease, Medicine +15